Save the Date for Applied Pharmaceutical Analysis 2019!

September 9-11, 2019

Revere Hotel Boston Common 
200 Stuart Street 
Boston, MA 02116

 

APA 2019 Plenary Speakers 

Paula Annunziato  

Paula Annunziato, MD, Vice President and Therapeutic Head, Vaccines Clinical Research, Merck

Vaccine Development - Title TBA

  Samir Hanash  

Samir M. Hanash, MD, PhD, Professor, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center

Mining the Proteometabolome for Precision Medicine

             
Nina Isoherrenan  

Nina Isoherranen, PhD, Professor, Vice Chair, Pharmaceutics, Department of Pharmaceutics, University of Washington

Predicting in vivo Drug–Drug Interactions Involving Multiple Precipitants

  Irina Koroleva  

Irina Koroleva, PhD, Director, Translational Medicine, Rubius Therapeutics

Title TBA

 

APA 2019 Confirmed Speakers

AWS Patrick Combes  

Patrick Combes, Amazon Web Services Worldwide Technical Leader - Healthcare and Life Sciences

Title TBA

   Scott Davis APA2019  

 

Scott Davis, Associate Director, Information Technology, PPD Bioanalytical and Vaccine Laboratory

Data Storage in the Cloud

             
 04 zoom in Sanne Demandt  

Sanne Demandt, PhD, Group Leader, Charles River Laboratories, Leiden

Advances and Challenges for T Cell Therapies

  Jaya Goyal APA2019  

Jaya Goyal, PhD, Vice President, Bioanalytical, Pharmacology and Biomarker Development, Wave Life Sciences, Ltd.

Combinatorial Approaches for Bioanalysis of Stereopure Oligonucleotides

             
Klarissa Jackson APA2019  

Klarissa Jackson, PhD, Professor, University of North Carolina Chapel Hill Eshelman School of Pharmacy

Metabolic Activation of Tyrosine Kinase Inhibitors by Cytochromes P450: Impact of Interindividual Variation

   Liang Jin APA2019  

Liang Jin, PhD, Senior Scientist, DMPK, AbbVie Bioresearch Center

Improve Target Discovery from Label-Free Proteomic Data from Machine Learning Algorithms

             
Priyanka Kulkarni APA2019  

Priyanka Kulkarni, PhD, Scientist, Pharmacokinetics and Drug Metabolism, Amgen

Modeling and Simulation to Study the Impact of Transporter-Enzyme Interplay on Drug-Drug Interactions

  Russell Mortshire  

Russell Mortishire-Smith, PhD, Senior Consulting Scientist, Applied Informatics, Scientific Operations, Waters Corporation

Approaches to Real Time Prediction of Collision Cross Section Values

             
Mireia Fernandez Ocana  

Mireia Fernandez Ocana, PhD, Biomarker Discovery Lead, Pfizer

Immunoaffinity LC-MS/MS Technologies for Translational Safety Biomarker Development

   Leila Pirhaji APA2019  

Leila Pirhaji, PhD, Founder and CEO, ReviveMed

Translating Metabolomics into Therapeutics Insights using Artificial Intelligence

             
Terry Podoll head shot page 001  

Terry Podoll, PhD, Principal Consultant, IV/PO LLC

Acalabrutinib Bioavailability, Biotransformation, and Excretion using a Microtracer and Tang, the Human ADME Formulation Every Mother Trusts

   Brooke Rock APA2019  

 

Brooke Rock, PhD, Principal Scientist, Pharmacokinetics and Drug Metabolism, Amgen

Transforming Traditional SM ADME Assays to Support the Translation of siRNA Pharmacology from the Benchtop to the Clinic

             
MTL HR  

Magdalena Tary-Lehmann, MD, PhD, Co-Founding Scientist and CSO, Cellular Technology Limited

Immunogenicity Assessment in Support of Gene Therapy Program-Use of ELISPOT Technology

     

 

             
Yu Tian  

Yu Tian, PhD, Director, Non-Regulated Bioanalysis Department, AbbVie Bioresearch Center

An Integrative Proteogenomics Pipeline Identifying Differentially Expressed Splicing Variants from IDB Patients

   Jingjing APA2019  

 Jingjing Yu, MD, PhD, Associate Director, University of Washington Drug Interaction Database Program

Mechanistic Analysis of Pharmacokinetic-Based Drug-Drug Interactions with Recently Marketed Drugs: from in vitro to Clinical Relevance

             

 

Arjun Arumugam, M.D., Executive Director, Azidus Laboratories Limited

David Burrow, Ph.D., Director, Office of Scientific Investigations, CDER, U.S. Food and Drug Administration

Prashant Desai, Ph.D., Research Advisor and Group Leader, Eli Lilly

Mark Dysinger, Development Scientist, Bioanalytical Development, Alexion Pharmaceuticals

Huidong Gu, Senior Research Scientist II, Bristol-Myers Squibb

Sam Haidar, Ph.D., Senior Advisor, OSIS/OTS/CDER, U.S. Food and Drug Administration

Hyunyoung (Young) Jeong, Ph.D., Professor, University of Illinois at Chicago

Amit Kalgutkar, Ph.D., Research Fellow, Pfizer

Colleen Kelly, M.D., Assistant Professor of Medicine, The Warren Alpert Medical School, Brown University

Dan (Youngjae) Kim, Ph.D., Associate Director, AbbVie

Seema Kumar, Ph.D., Associate Director, EMD Serono

Luna Liu , M.S., Principle Scientific Researcher, Genentech

Jean-Claude Marshall, Ph.D., Head of Clinical Biomarker Technologies, Pfizer

Katie Matys, M.S., Associate Director, PPD

Mark Milton, Ph.D., Ophthalmology Therapeutic Area Head, PK Sciences, Novartis Institutes for BioMedical Research (NIBR)

Kaushik Mitra, Ph.D., Director, Molecular and Investigative Toxicology, Merck

Lisa O'Callaghan, Ph.D., Associate Principal Scientist, Merck

James Schiller, Director, Merck

Michael Skelly, Ph.D., Lead Pharmacologist, CDER/OTS/OSIS, U.S. Food and Drug Administration

Ajit Suri, Ph.D., Senior Scientific Director, Quantitative Clinical Pharmacology, Takeda Pharmaceuticals

Esther van Duijn, Ph.D., Scientist, TNO (Netherlands Organisation for Applied Scientific Research)

Sheri Wilcox, Senior Director, SomaLogic

Fan Wu, Senior Principal Scientist, Celgene Corporation

Yuching Yang, Ph.D., Clinical Pharmacometrics Reviewer, U.S. Food and Drug Administration

Li Yu, Ph.D., Pharmaceutical Sciences Site Head NY and DMPK/PD Leader, Roche

Xu (Sue) Zhu, Ph.D., Senior Scientist, Novartis Institutes for Biomedical Research

 

Sessions for APA 2019 Workshops 

Regulated Bioanalysis

FDA/Regulatory Session

Digital State of Regulated Bioanalysis

Bioanalytical Support of Novel Therapies and New Modalities in Clinical Development

Implementation of 2018 FDA BMV Guidance/ICH M10

Frontiers of Biomarker Bioanalysis

Discovery Bioanalysis and New Technologies

Novel modalities, guidance for new modalities

Cellular and Gene Therapies

Omics

Advanced LC-MS and Applications of HRMS

AI Session - Predict the Structure

Mechanistic ADME

Not Your Average Human ADME Study

Toxicity and Drug Metabolism: Advances in the Mechanistic Understanding that Inform Risk Management

Improved Clinical Outcomes Through Modeling

Insights and Development Challenges of New Modalities

From Accidents to Innovation: Serendipity in Drug Discovery

 

Expanding Horizons - Beyond Mechanistic ADME and Bioanalysis Workshop (NASH/Fibrosis/Microbiome)

 

APA 2018 Conference Program

 

 Join our Linkedin Group:

Workshops

Regulated Bioanalysis

Discovery

Mechanistic ADME

Registration

Click here to register for the APA 2019 conference online.

APA 2019 will take place September 9th-11th, 2019 at:

Revere Hotel Boston Commmon

Boston, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy